This study showed that APP/PS1 transgenic AD mice showed progressive structural and functional damage to the mLVs and dCLNs from 6 months of age without exogenous intervention, manifested by decreased LYVE-1 expression and reduced tracer drainage efficiency. Here, LYVE1 is linked to Alzheimer disease.